‘Legal Highs’ – novel and emerging psychoactive drugs: a chemical overview for the toxicologist

References

• McNabb CB, Russell BR, Caprioli D, Nutt DJ, Gibbons S, Dalley JW. Single chemical entity legal highs: assessing the risk for long term harm. Curr Drug Abuse Rev 2011; (Submitted).
   Google Scholar
• Winstock AR, Ramsey JD. Legal highs and the challenges for policy makers. Addiction 2010; 105:1685–1687.
   PubMed Web of Science ®Google Scholar
• Gibbons S, Zloh M. An analysis of the legal high mephedrone. Bioorg Med Chem Lett 2010; 20:4135–4139.
   PubMed Web of Science ®Google Scholar
• http://www.homeoffice.gov.uk/publications/alcohol-drugs/drugs/acmd1/acmd-cathinodes-report-2010.
   Google Scholar
• Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219:979–980.
   PubMed Web of Science ®Google Scholar
• Langston JW, Irwin I, Langston EB, Forno LS. 1-Methyl-4-phenylpyridinium ion (MPP +): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett 1984; 48:87–92.
   PubMed Web of Science ®Google Scholar
• Benyhe S. Morphine: new aspects in the study of an ancient compound. Life Sci 1994; 55:969–979.
   PubMed Web of Science ®Google Scholar
• Appendino G, Chianese G, Taglialatela-Scafati O. Cannabinoids: occurrence and medicinal chemistry. Curr Med Chem 2011; 18: 1085–1099.
   PubMed Web of Science ®Google Scholar
• Harvey AL, Young LC, Viljoen AM, Gericke NP. Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids. J Ethnopharmacol 2011; 137:1124–1129.
   PubMed Web of Science ®Google Scholar
• Michelot D, Melendez-Howell LM. Amanita muscaria: chemistry, biology, toxicology, and ethnomycology. Mycol Res 2003; 107: 131–146.
   PubMed Web of Science ®Google Scholar
• Brown SD, Melton TC. Trends in bioanalytical methods for the determination and quantification of club drugs: 2000–2010. Biomed Chromatogr 2011; 25:300–321.
   PubMed Web of Science ®Google Scholar
• Palmer RB. Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate. Toxicol Rev 2004; 23:21–31.
   PubMedGoogle Scholar
• Wood DM, Brailsford AD, Dargan PI. Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). Drug Test Anal 2011; 3:417–425.
   PubMed Web of Science ®Google Scholar
• Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther 2004; 102:131–138.
   PubMed Web of Science ®Google Scholar
• Daly JW, Spande TF, Garraffo HM. Alkaloids from amphibian skin: a tabulation of over eight-hundred compounds. J Nat Prod 2005; 68:1556–1575.
   PubMed Web of Science ®Google Scholar
• Daly JW. Nicotinic agonists, antagonists, and modulators from natural sources. Cell Mol Neurobiol 2005; 25:513–552.
   PubMed Web of Science ®Google Scholar
• McLaughlin JL. Peyote: an introduction. Lloydia 1973; 36:1–8.
   PubMedGoogle Scholar
• Kalix P. The pharmacology of psychoactive alkaloids from Ephedra and Catha. J Ethnopharmacol 1991; 32:201–208.
   PubMed Web of Science ®Google Scholar
• Klein A, Metaal P. A good chew or good riddance–how to move forward in the regulation of khat consumption. J Ethnopharmacol 2010; 132:584–589.
   PubMed Web of Science ®Google Scholar
• Pemberton IJ, Smith GR, Forbes TD, Hensarling CM. Technical note: an improved method for extraction and quantification of toxic phenethylamines from Acacia berlandieri. J Anim Sci 1993; 71:467–470.
   PubMed Web of Science ®Google Scholar
• Gjessing L, Armstrong MD. Occurrence of (-)-sympatol in oranges. Proc Soc Exp Biol Med 1963; 114:226–229.
   PubMed Web of Science ®Google Scholar
• Rossato LG, Costa VM, Limberger RP, Bastos Mde L, Remião F. Synephrine: from trace concentrations to massive consumption in weight-loss. Food Chem Toxicol 2011; 49:8–16.
   PubMed Web of Science ®Google Scholar
• Brunt TM, Poortman A, Niesink RJ, van den Brink W. Instability of the ecstasy market and a new kid on the block: mephedrone. J Psychopharmacol 2011; 25:1543–1547.
   PubMed Web of Science ®Google Scholar
• Cozzi NV, Sievert MK, Shulgin AT, Jacob P 3rd, Ruoho AE. Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 1999; 381:63–69.
   PubMed Web of Science ®Google Scholar
• Schifano F, Albanese A, Fergus S, Stair JL, Deluca P, Corazza O, . Psychonaut Web Mapping; ReDNet Research Groups. Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues. Psychopharmacology (Berl). 2011; 214:593–602.
   PubMed Web of Science ®Google Scholar
• Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T. Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats. Br J Pharmacol 2011; 164:1949–1958.
   PubMed Web of Science ®Google Scholar
• http://www.homeoffice.gov.uk/publications/alcohol-drugs/drugs/acmd1/acmd-cathinodes-report-2010.
   Google Scholar
• Gorceix A, Jacquemin C. Value of pyrovalerone in the ambulatory treatment of fatigue states. Ann Med Psychol (Paris) 1970; 2:624–632.
   PubMedGoogle Scholar
• Meltzer PC, Butler D, Deschamps JR, Madras BK. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 2006; 49:1420–1432.
   PubMed Web of Science ®Google Scholar
• http://www.homeoffice.gov.uk/drugs/drug-law/naphyrone/
   Google Scholar
• Nichols DE, Brewster WK, Johnson MP, Oberlender R, Riggs RM. Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA). J Med Chem 1990; 33:703–710.
   PubMed Web of Science ®Google Scholar
• Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE. Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine. J Med Chem 1993; 36:3700–3706.
   PubMed Web of Science ®Google Scholar
• Marona-Lewicka D, Nichols DE. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-amino indan. Eur J Pharmacol 1994; 258:1–13.
   PubMed Web of Science ®Google Scholar
• Wood DM, Button J, Lidder S, Ovaska H, Ramsey J, Holt DW, Dargan PI. Detection of the novel recreational drug Diphenyl-2-pyrrolidinemethanol (D2PM) sold legally in combination with 1-Benzylpiperzaine (BZP). Clin Toxicol 2008; 46:393.
   Web of Science ®Google Scholar
• Corey EJ, Bakshi RK, Shibata S. Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines Mechanism and synthetic implications. J Am Chem Soc 1987; 109:5551–5553.
   Web of Science ®Google Scholar
• Perlstein IB. The use of pipradrol in the problems of obesity. Int Rec Med Gen Pract Clin 1957; 170:55–58.
   PubMedGoogle Scholar
• Ross SB, Kelder D. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum. Acta Pharmacol Toxicol (Copenh) 1979; 44:329–335.
   PubMedGoogle Scholar
• Ursillo RC, Jacobsen JJ. Potentiation of norepinephrine in the isolated vas deferens of the rat by some CNS stimulants and antidepressants. J Pharmacol Exp Ther 1965; 148:247–251.
   PubMed Web of Science ®Google Scholar
• Tripod J, Sury E, Hoffmann K. Analeptic effect of a new piperidine derivative. Experientia 1954; 10:261–262.
   PubMedGoogle Scholar
• Ferris, RM, Tang FL. Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-3H-norepinephrine and 3H-dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. J Pharmacol Exp Ther 1979; 210:422–428.
   PubMed Web of Science ®Google Scholar
• James DA, Potts S, Thomas SHL, Chincholkar VM, Clarke S, Dear J, Ramsey J. Clinical features associated with recreational use of ‘Ivory Wave’ preparations containing desoxypipradrol. Clin Toxicol 2011; 49:201.
   Web of Science ®Google Scholar
• http://www.homeoffice.gov.uk/media-centre/news/drug-import-ban.
   Google Scholar
• Iversen SD, Iversen LL. Dopamine: 50 years in perspective. Trends Neurosci 2007; 30:188–193.
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Devane CL, Boulton DW, Nahas Z, Risch SC, Diamond F, . Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. Drug Metab Dispos 2000; 28:620–624.
   PubMed Web of Science ®Google Scholar
• Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE Jr, Middaugh LD. Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. J Med Chem 2005; 48:2876–2881.
   PubMed Web of Science ®Google Scholar
• Woolverton WL, Balster RL. Effects of local anesthetics on fixed-interval responding in rhesus monkeys. Pharmacol Biochem Behav 1983; 18:383–387.
   PubMed Web of Science ®Google Scholar
• Graham JH, Balster RL. Cocaine-like discriminative stimulus effects of procaine, dimethocaine and lidocaine in rats. Psychopharmacology 1993; 110:287–294.
   PubMed Web of Science ®Google Scholar
• Wilcox KM, Kimmel HL, Lindsey KP, Votaw JR, Goodman MM, Howell LL. In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys. Synapse 2005; 58:220–228.
   PubMed Web of Science ®Google Scholar
• Morgan CJ, Curran HV; the Independent Scientific Committee on Drugs (ISCD). Ketamine use: a review. Addiction 2011; 107:27–38.
   PubMed Web of Science ®Google Scholar
• McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med 1981; 10:237–242.
   PubMed Web of Science ®Google Scholar
• Wood D, Cottrell A, Baker SC, Southgate J, Harris M, Fulford S, . Recreational ketamine: from pleasure to pain. Brit J Urol 2011; 107:1881–1884.
   Google Scholar
• Lyttle T, Goldstein D, Gartz J. Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic. J Psychoactive Drugs 1996; 28:267–290.
   PubMed Web of Science ®Google Scholar
• Nonaka R, Nagai F, Ogata A, Satoh K. In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes. Biol Pharm Bull 2007; 30:2328–2333.
   PubMed Web of Science ®Google Scholar
• Nagai F, Nonaka R, Satoh Hisashi Kamimura K. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 2007; 559:132–137.
   PubMed Web of Science ®Google Scholar
• Beckett AH, Shellard EJ, Phillipson JD, Lee CM. Alkaloids from Mitragyna speciosa (Korth.). J Pharm Pharmacol 1965; 17:753–755.
   PubMed Web of Science ®Google Scholar
• Lee CM, Trager WF, Beckett AH. Corynantheidine-type alkaloids. II. Absolute configuration of mitragynine, speciociliatine, mitraciliatine and speciogynine. Tetrahedron 1967; 23:375–385.
   PubMed Web of Science ®Google Scholar
• Thongpradichote S, Matsumoto K, Tohda M, Takayama H, Aimi N, Sakai S, Watanabe H. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice. Life Sci 1998; 62:1371–1378.
   PubMed Web of Science ®Google Scholar
• Hylin JW, Watson DP. Ergoline alkaloids in tropical wood roses. Science 1965; 148:499–500.
   PubMed Web of Science ®Google Scholar
• Van Hout MC, Brennan R. ‘Heads held high’: an exploratory study of legal highs in pre-legislation Ireland. J Ethn Subst Abuse 2011; 10:256–72.
   PubMedGoogle Scholar
• Klinke HB, Müller IB, Steffenrud S, Dahl-Sørensen R. Two cases of lysergamide intoxication by ingestion of seeds from Hawaiian Baby Woodrose. Forensic Sci Int 2010; 197:e1–e5.
   PubMed Web of Science ®Google Scholar
• Siebert DJ. Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 1994; 43:53–56.
   PubMed Web of Science ®Google Scholar
• Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 2002; 99:11934–11939.
   PubMed Web of Science ®Google Scholar